Retos en la identificación de fentanilo y sus análogos en México: Implicaciones para la salud pública

• González Lozano, Rafael Uriel ^[1]
  1. [1] Fiscalía General de la República
• Localización: Adicciones: Revista de socidrogalcohol, ISSN 0214-4840, Vol. 38, Nº. 3, 2026, págs. 203-204
• Idioma: español
• Títulos paralelos:
  • Challenges in the identification of fentanyl and its analogues in Mexico: Implications for public health
• Enlaces
  • Texto completo  1    2  
• Referencias bibliográficas
  • Armenian, P., Vo, K. T., Barr-Walker, J., & Lynch, K. L. (2018). Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive...
  • Centers for Disease Control and Prevention (CDC). (2024). Overdose prevention. https://www.cdc.gov
  • European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2024). European Drug Report 2024.
  • Gonzalez Lozano, R. U., Morales Zárate, J. I., & Rebollar López, E. J. (2024). Revisión documental de fentanilo. Revista Mexicana de Ciencias...
  • O’Donnell, J., Gladden, R. M., Goldberger, B. A., Mattson, C. L., & Kariisa, M. (2020). Notes from the Field: Opioid-Involved Overdose...
  • O’Donnell, J. K., Gladden, R. M., & Seth, P. (2020). Trends in deaths involving heroin and synthetic opioids. MMWR Morbidity and Mortality...
  • Scientific Working Group for the Analysis of Seized Drugs (SWGDRUG). (2021). Recommendations. https://www.swgdrug.org
  • United Nations Office on Drugs and Crime (UNODC). (2009). Guidelines on Representative Drug Sampling. United Nations.
  • United Nations Office on Drugs and Crime (UNODC). (2023). World Drug Report 2023.